(Q35261991)

L-histidinol in experimental cancer chemotherapy: improving the selectivity and efficacy of anticancer drugs, eliminating metastatic disease and reversing the multidrug-resistant phenotype (English)

1 reference

stated in

Europe PubMed Central

7 August 2017

multiple drug resistance

1 reference

R. C. Warrington

1

1 reference

stated in

Europe PubMed Central

PubMed ID

1353969

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1353969

retrieved

17 September 2022

language of work or name

English

1 reference

stated in

National Center for Biotechnology Information

PubMed ID

1353969

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1353969

retrieved

17 September 2022

publication date

1 May 1992

1 reference

stated in

Europe PubMed Central

7 August 2017

Biochemistry and Cell Biology

1 reference

stated in

Europe PubMed Central

7 August 2017

70

1 reference

stated in

Europe PubMed Central

7 August 2017

5

1 reference

stated in

Europe PubMed Central

7 August 2017

365-375

1 reference

stated in

Europe PubMed Central

PubMed ID

1353969

retrieved

7 August 2017

Identifiers

0 references

1 reference

Europe PubMed Central

PubMed ID

1353969

retrieved

7 August 2017

(Q35261991)

L-histidinol in experimental cancer chemotherapy: improving the selectivity and efficacy of anticancer drugs, eliminating metastatic disease and reversing the multidrug-resistant phenotype

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)